Hycolin Antiviral Cleaner

The Hycolin Multipurpose Antiviral Surface Cleaner becomes one of the first cleaning solutions to be proven effective against the SARS-CoV-2 virus which is the novel coronavirus that causes COVID-19.

Hycolin Multipurpose Antiviral Surface Cleaner has been tested against the SARS-CoV-2 virus by scientists using the NEN 14675 Standard Method and has been proven and certified to be e­ffective against the Novel Coronavirus that is the cause of COVID-19.

Until now, disinfectant cleaners claiming to be effective against Coronavirus have usually been tested against a surrogate virus that was only similar to SARS-CoV-2 (COVID-19), not the virus that causes COVID-19 itself. Wageningen Bioveterinary Research Institute (WBVR), have tested the Hycolin Multipurpose Antiviral Surface Cleaner against SARS-CoV-2 which causes COVID-19. The Hycolin Multipurpose Antiviral Surface Cleaner was demonstrated to kill over 99% of the SARS-CoV-2 virus in less than 5 minutes contact.

WBVR, working in collaboration with the University of Wageningen in the Netherlands, is a global leader in science and is well-known and respected for its research into infectious diseases, notably in the important discipline of virology. The WBVR collaborates with public and private partners to safeguard animal and public health through prevention, eradication, and control of diseases. Research institutes like the WBVR are understandably deeply engaged in the science of the COVID-19 pandemic. To achieve their admirable and very necessary objectives the WBVR routinely handles viruses that are not available to the wider scientific community including laboratories that provide commercial disinfectant (antiviral) product testing services.

Due to the limited availability of the SARS-CoV-2 virus in laboratories around the world, the usual approach to the assessment of ‘antiviral’ disinfectant products is to test the product against surrogate viruses that are used as replacements for the unavailable SARS-CoV-2 virus. However, obtaining an independently generated, empirical result of an antiviral product’s performance against the virus that causes COVID-19 is definitive and the ultimate goal in the context of antiviral disinfectant testing. WBVR have combined Hycolin Antiviral Disinfectant with the SARS-CoV-2 virus according to the specifications of the NEN 14675 Standard Method in order to measure the inactivation effect of Hycolin on the COVID-19 virus.